Local officials want to help Tucson bioscience companies fill jobs locally.
Investors are the lifeblood of bioscience and health-care innovation.
Tucson-based Accelerate Diagnostics Inc. said it will raise $20 million by offering existing shareholders rights to buy new shares of its publicly traded stock.
Accelerate CEO Lawrence Mehren
To Larry Mehren, CEO of Accelerate Diagnostics, moving the company from Denver to Tucson was "all about potential."
CEO Larry Mehren talked about the bio-lab to a few folks Thursdasy while others get a tour through the lab itself during an open house for the new headquarters and labs for Accelerate Diagnostics, 3950 S. Country Club Road.
A Denver company is moving to Tucson with ambitious growth plans and hopes of creating a biotech hub to attract scientists and engineers.
The University of Arizona is adding two new research buildings
on the north side of Speedway to its wish list.